Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» aficamten
aficamten
Novartis in advanced talks to buy Cytokinetics
Reuters
Mon, 01/8/24 - 10:29 pm
Novartis
Cytokinetics
M&A
aficamten
Cytokinetics' heart failure drug improves exercise capacity, sending shares soaring in long-awaited win
Fierce Biotech
Wed, 12/27/23 - 11:06 pm
Cytokinetics
cardiomyopathy
aficamten
heart failure
Cytokinetics initiates trial of aficamten to treat nHCM
Clinical Trials Arena
Thu, 09/7/23 - 10:47 am
Cytokinetics
clinical trials
aficamten
non-obstructive hypertrophic cardiomyopathy
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
Clinical Trials Arena
Mon, 04/24/23 - 11:23 am
Cytokinetics
clinical trials
ALS
reldesemtiv
cardiomyopathy
aficamten